Endovascular Function in Atrial Fibrillation (AF) Patients (HEAF)
Endovascular Function in Patients With Atrial Fibrillation
- recruit 50 patients with atrial fibrillation and 30 controls
- endovascular function assessment with Peripheral Arterial Tonometry (PAT)
- follow up the occurence of AF
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Beijing, China, 100020
- Recruiting
- Beijing Chaoyang Hospital
-
Contact:
- Lin Han, Bachelor
- Phone Number: 86-10185231512
-
Principal Investigator:
- Guangzhen Zhong, Doctor
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- ≥2 paroxysmal (electrocardiographic documentation of at least 1) AF episodes lasting ≥1 hour in duration: (that terminate spontaneously within 7 days or cardioversion is performed within 48h of AF onset): or
- electrocardiographic documentation of 1 persistent AF episode: (sustained for ≥7 days or cardioversion is performed more than 48h after AF onset): or
- electrocardiographic documentation of 1 longstanding persistent AF episode: (continuous AF of duration >1 year).
Exclusion Criteria:
- patients with cerebralvascular disease
- patients with coronary disease
- patients with peripheric artery disease
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
endovascular function results
Time Frame: Up to 24 weeks.
|
The method to assess the endovascular function is PAT.
The index is Reactive hyperemia index (RHI).
RHI between patients and control will be compared.
|
Up to 24 weeks.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
predictive effect of endovascular function on recurrence of AF
Time Frame: Up to 1 year
|
We will do the multi-logistic analysis of the recurrence of AF.
|
Up to 1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- NF81300148
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.